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Phenylketonuria (PKU) is an inherited metabolic disorder in which the patient cannot metabolise 
phenylalanine into tyrosine and other metabolites which leads to irreversible brain damage and 
neurological disorders if left untreated. The majority of the patients are treated using dietary 
therapy where the patient receives an amino acid based protein supplement. However these 
supplements exhibit poor organoleptic properties due to the bitter and sulphurous nature of certain 
amino acids, which can lead to poor patient compliance. 
In order to reduce the negative organoleptic attributes masking technologies have been previously 
applied but have only had limited success. Therefore the use of alginate beads was investigated to 
encapsulate the amino acids. Although the use of alginate beads for encapsulation is well known and 
are used for pharmaceutical materials, the techniques had not been applied to amino acids.  
Therefore there was no prior knowledge of how to construct the beads, and the effect of 
encapsulation on the organoleptic properties and amino acid bioavailability.   Experiments were 
undertaken to firstly develop and refine the method of manufacture utilising laser particle defraction 
techniques to determine bead size and nitrogen content quantification by Dumas to determine 
amino acid recovery. Initially the beads manufactured where too large, in excess of 2mm, however 
by reducing the aperture of the nozzle used to produce the droplet and milling the amino acids to a 
finer particle size it was possible to produce beads between 1 and 2mm, which was the optimal size 
for the beads to avoid gastric straining and aid the transit of the beads through the stomach. 
A design of experiment methodology was then implemented to determine the relationship between 
the factors; calcium content, alginate content and the time in the gelling solution, and the amino 
acid recovery (output). The amino acid content remained constant at 10% (w/w) throughout the 
experiments.  It was found that the alginate and time in the gelling solution had a significant effect 
on the amino acid recovery when the calcium chloride concentration was between 10 and 30% 
(w/w). The best recovery, of 78%, was produced with a bead containing 10% (w/w) amino acid and 
3% (w/w) alginate using a 30% (w/w) calcium chloride gelling solution and a 1 minute residence 
time. 
The beads were subjected to an in vitro digestion model and it was found that the amino acids 
encapsulated in the beads were still bioavailable as there was a reduction in amino acid content of 
the beads from 10g/100g of bead to 2.95 g/100g of bead after in vitro digestion. 
To determine if the encapsulation had had an effect on the sensory attributes a triangle test with a 
maltodextrin containing placebo was carried out. In the test 12 expert panellists trained in tasting 
amino acid products tasted the beads and only 6 panellists identified the different sample. This was 
less than the 8 correct identifications needed for significance at 95% and therefore the beads could 
not be identified from the placebo. Therefore the method applied successfully produced an amino 
acid alginate bead that masked the flavour but did not compromise the bioavailability.  
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1. Literature Review 
1.1 Introduction 
1.1.1 Disorders of Amino Acid Metabolism 
Protein is a major component of living cells and comprises 17% of the weight of an adult (Emery, 
2015) . On consumption proteins are digested in the stomach and small intestine using enzymes that 
hydrolyse the proteins to poly peptides which are further digested into amino acids which enter the 
circulatory system. Once in the body the amino acids have three outcomes; they can be oxidised 
utilising transamination and excreted as urea, combined with other amino acids to produce proteins 
or be metabolised to produce non protein molecules (Emery, 2015). 
However in some individuals with certain inherited metabolic disorders the enzymes or proteins 
required for the metabolism to non-protein molecules is defective which can lead to the formation 
of alternative or intermediate products that can have acute or toxic effects. Examples of such 
disorders are maple syrup urine disorder which affects the metabolism of branched chain amino 
acids, homocystinuria affecting methionine metabolism, tyrosinaemias affecting tyrosine 
metabolism and phenylketonuria affecting phenylalanine metabolism (Shaw, 2015). 
1.1.2  Phenylketonuria  
Phenylketonuria is present in around  1:10,000 live births in Europe (Blau, 2010) and is an is an 
autosomal recessive  inborn error caused by certain mutated genes . As it is an autosomal recessive 
inherited condition the faulty genes are passed down from the parents to child, which results in 
either the child being a gene carrier or developing the condition.  Phenylalanine is an essential amino 
acid and has two functions within the body; firstly the synthesis of tissue protein and secondly being 
hydroxylated to form tyrosine (Shaw, 2015). 
In the normal metabolic pathway phenylalanine is metabolised in the liver utilising the 
phenylalanine hydroxylase (PAH) system which converts phenylalanine to tyrosine. The PAH system 
also requires the use of the tetrahydrobiopterin enzyme (BH4) which during the hydrolysis reaction is 
converted to dihydrobiopterin (BH2), but is regenerated by dihydrobiopterin reductase (qBH2) (figure 















Figure 1.0 Hydroxylation of Phenylalanine  (Shaw, 2015) 
In a patient with phenylketonuria there is a reduction in activity or defect in either the PAH system 
or the BH4 recycling system (Walter, 2012). This leads to the inhibition of hydroxylation of 
phenylalanine leading to an increase in the levels of phenylalanine in the blood from a normal level 
of around 2 to 10 mg/l to greater than 20mg/l (Acosta, 2010). This abnormal level of phenylalanine 
crosses the blood brain barrier and enters the brain acting like a neurotoxin, the mechanism of 
which is not fully understood (Imperlini, 2014). 
The reduction in these systems also leads to a reduction in tyrosine which is not being produced 
from phenylalanine. If the phenylketonuria is caused by a defect in the BH4 recycling system then the 
levels of BH4 will be reduced. This leads to a reduction in the rate of activity of tyrosine hydroxylase 
and tryptophan hydroxylase as BH4 is co-factor in these reactions.  The effect of this is to reduce the 
synthesis of biogenic amines normally produced by those reactions such as dopamine, serotine and 
norepinephrine which are important for normal brain function (Walter, 2012).  In addition high 
phenylalanine levels in the blood affects the transport of other large neutral amino acids to the 
brain, which further reduces the levels of tyrosine and serotonin (Walter, 2012). 
These abnormal biochemical changes lead to brain dysfunctions although the actual mechanisms are 
not understood (Imperlini, 2014).  These dysfunctions are presented by mental symptoms, with 
significant delays in developmental milestones, hyperactivity with autistic features and seizures. In 
addition there are also physical symptoms with eczema, a musty skin colour and light pigmentation 
being typical. If untreated the damage to the brain is irreversible with lifelong disability to the 
patient (Christ, 2010) with untreated patients not possessing the abilities for self-care or 
independent living (Acosta, 2010).   
However the brain damage and poor outcomes can be avoided with early detection at birth and the 
use of measures to control the blood phenylalanine level. In the developed world this is achieved by 
new born screening via a heel prick  blood test. In the UK blood is taken from the heel of a baby 
within 5 to 8 days of birth and tested for phenylalanine and tyrosine using tandem mass 
spectrometry (Shaw, 2015). If there is a level of 240µmol/l of phenylalanine or higher, and, or a 
phenylalanine to tyrosine ratio greater than 3 then child may be suffering from PKU, and further 




There are several different treatment options that can be applied to reduce and control the blood 
phenylalanine level and include gene therapy, enzyme replacement therapy, amino acid transport 
competition at the blood brain barrier and dietary management (figure 1.1). 
 
 
Figure 1.1 Different treatment options available for PKU at different body locations (Sprosen, 2010) 
However some of these treatment options are not currently available to the patient, with gene and 
cell therapy being only at a pre-clinical stage and enzyme therapy currently only used in human 
trials. The current mainstay treatment throughout the world is by dietary management utilising a 
phenylalanine restricted diet (Sprosen, 2010). 
In this diet the amount of natural protein from food sources is controlled and is mainly a very low 
protein diet containing mostly fruits and vegetables, which are low in. Produce that is high in protein 
thus high in phenylalanine,  such as meat, fish and dairy products is controlled or excluded from the 
diet depending upon the severity of the PKU. As phenylalanine is an essential amino acid a small 
amount is required to be present in the diet so a small amount of protein is permitted. Foods 
naturally low in phenylalanine containing less than 20 – 25 mg phenylalanine per 100g, are freely 
permitted for consumption (Ahring, 2009) and are generally fruits, vegetables, certain cereals, fats 
and oils.  
However it is not possible to thrive on a low protein diet alone, as protein is required to remain 
healthy and the diet avoids certain food groups it is deficient in certain micronutrients. Therefore 
the patients consume a protein replacement supplement daily, containing a source of L amino acids 
and micronutrients that mimics the amino acid composition of a normal diet containing meat, fish 
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and dairy products, but is free from phenylalanine (table 1.0). The amount of supplement consumed 
depends upon the protein requirement of the patient and is related to their age, weight and activity 
levels.  
Table 1.0  Typical amino acid composition of a PKU protein supplement  
Amino acid  g per 100g supplement 
L-Alanine   0.93 
L-Arginine  1.6 
L-Aspartic Acid  1.4 
L-Cystine  0.41 
Glycine  1.5 
L-Histidine   0.63 
L-Isoleucine  0.99 
L-Leucine   1.7 
L-Lysine   1.3 
L-Methionine   0.27 
L-Phenylalanine   nil 
L-Proline   1.6 
L-Serine   0.87 
L-Threonine   0.83 
L-Tryptophan   0.33 
L-Tyrosine   1.5 
L-Valine   1.1 
L-Carnitine  0.01 
Taurine  0.08 
(SHS 2010) 
If this diet is followed the long term outcome of the patient is good with most patients health and 
wellbeing markers comparable to the healthy population (Shaw, 2015). As the patients get older the 
need for the supplementation reduces as the brain is less plastic, and the patients generally show 
less motivation to maintain the diet as the effects are less immediate.  However it is important to 
remain on diet as elevated phenylalanine levels can lead to neurological effects such as an increase 
in irritability, poor concentration, headaches and a reduction in quality of life scores. The PKU 
patient is generally unaware of these symptoms and they are usually reported by family members, 
but if the patient returns on diet these symptoms alleviate and the quality of life score increases 
(Macleod, 2010).  
1.1.3 Compliance 
Compliance is an indicator of a patient’s behaviour, a fully compliant patient would be consuming 
their protein supplement, following the diet and attending clinic as per the prescriber’s 
recommendations (MacDonald, 2010).  In PKU it is well known that significant non-compliance exists 
with only 38% of young people consuming all the required amount of protein supplement, and 
between 57% to 75% consuming less than prescribed,  which can lead to a failure to thrive and an 
increase in serum phenylalanine levels due to patients being off a phenylalanine-restricted and low 
protein diet (Macdonald, 2000). Compliance can be influenced by many factors from cultural and 
environmental factors such as the stigma of PKU and the availability of health care, family support 
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and convenience of the protein supplement.  Emotional and physiological factors can also effect 
compliance and it is well known that the unsatisfactory organoleptic properties of PKU supplements 
can be a barrier to the patients consuming as prescribed (Sarkissian, 1999) with both powdered and 
‘ready to drink’ products being  poor in terms of flavour and palatability (Gokmen-Ozel, 2009; Prince, 
1997). These poor organoleptic properties are an expression of flavour of the individual amino acids 
which can exhibit bitter and or sulphurous flavours especially the essential amino acids (highlighted 
in table 1.1 below) which are required to be within the supplement. 
Table 1.1  – Amino acids taste properties    
Amino Acid Taste - powder form Texture - powder form 
Taste - 5% water 
dilution 
Alanine Sweet Fine/gritty Sweet 
Arginine Bitter Gritty/Dissolving Bitter 
Aspartic Acid Sour Gritty Sour 
Cystine Neutral Gritty crystals Neutral 




Histidine Bitter Gritty Bitter 
Iso leucine Bitter, Beefy Flakes,crystalline Bitter 
Leucine Bitter Fine powder Bitter 
Lysine 
Glutamate Salty, cabbage, a bit of sweet Smooth, melts in mouth Umami, cabbage 
Lysine 
Hydrochloride Salty,  Bitter, Sour bubbly, gritty Bitter, sour, salty 
Methionine Beefy/cabbage, fishy Fine 
Beef/cabbage, burnt 
rubber 
Proline Sweet, bitter 
Gritty, dissolves in 
mouth Sweet, bitter 
Serine Sweet 
Gritty, dissolves in 
mouth Sweet, salty, umami 
Threonine Neutral, sweet Gritty Sweet, Neutral 
Tryptophan Bitter, sour, umami Fine Bitter, umami 
Tyrosine Neutral Smooth, melts in mouth Neutral. Umami 
Valine Bitter, sweet, salty Flaky, crystalline Bitter, sweet 
Asparagine 
Monohydrate Neutral Gritty Neutral, umami 
Glutamine Neutral, sweet Gritty Neutral, sweet, 
Lysine 
Acetate Sour, umami Gritty Sour, sweet, umami 
Carnitine Sweet, sour 
Hot in the mouth and 
dissolves Neutral. Bitter 
Taurine Neutral Gritty Neutral, Sour 
Lysine 
Aspartate Sour, umami Gritty Umami, sour 
Citrulline Sweet, Neutral 
Hot in the mouth and 
dissolves Sweet, slightly bitter 
Magnesium 
Aspartate Bitter, umami, 
 
Bitter, umami, cabbage 
Acetyl 





Therefore if a supplement could be produced that was convenient, with improved organoleptic 
characteristics from masking the negative attributes of amino acids, then this would aid compliance.  
1.2 Masking technologies   
Taste masking has been applied in both pharmaceutical and food industries for some years with 
differing techniques being applied to reduce negative flavour attributes.  Simple flavour masking 
techniques have been used for many years for PKU supplements, such as the addition of sucrose and 
sweeteners to mask unpleasant bitter notes, however these techniques are not very successful and 
therefore new approaches are necessary (Sohi, 2005) 
1.3 Double Emulsions 
One approach is the use of double emulsions. Double emulsions have been used for encapsulation of 
active or sensitive components in the pharmaceutical and cosmetics industries for several years and 
now this technology is being applied to the food industry for encapsulation. (Dickinson, 2011 )  
In a double emulsion, an emulsion is formed which is then used as the dispersed phase for another 
emulsion thus producing an emulsion within an emulsion.  They are manufactured using a 2 stage 
process, as seen in figure 1.2, in which an initial emulsion is formed from oil and water phases in 
combination with an oil soluble emulsifier and homogenisation. This water in oil emulsion is then 
combined with a water phase with a water soluble emulsifier to produce a water in oil in water 




Figure 1.2 Double emulsion manufacturing process (McClements, 2012) 
The component that is to be encapsulated is usually dispersed in water phase of the first emulsion, 
and as such is protected from interacting with the oral surfaces of the mouth  (Dickinson, 2011 )  and 
thus any negative attributes associated with the component are masked. 
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However double emulsions can prove difficult and expensive to manufacture when compared to a 
simple emulsion,  as two emulsions have to be produced involving  stabilising multiple interfaces 
with differing emulsifiers, compared to a simple emulsion with one interface and one emulsifier 
(Dickinson, 2011). In addition double emulsions are also prone to instability and are easily 
destabilised by environmental and mechanical factors such as freezing, dehydration, thermal 
processing, pumping and mixing (McClements, 2012).  
For an amino acid blend to be used in a PKU product the challenges are greater. Firstly, a large 
proportion of the pharmaceutical and cosmetic double emulsions use synthetic surfactants and 
polymers that are not permitted for use in a food product (Frash-Melnik, 2010). Double emulsions 
have been produced with food grade emulsifiers but the choices are limited with polyglycerol 
polyricinoleates (PGPR) being generally used for the initial water in oil phase and functional proteins 
used for the oil in water phase. 
The use of PGPR in a PKU product would be problematic as the provision under the 1995  
Miscellaneous Food Additives Regulations (1995:17) limits its use to low and very low fat spreads 
and dressings, and chocolate and chocolate based confectionary Therefore its use in a food for 
special medical purposes would not be permitted.   
There have, however, been double emulsions produced without PGPR by utilising small fat crystals 
to stabilise the initial water phase via the Pickering mechanism. In this process the oil blend used 
contains a saturated monoglyceride and tripalmitin which produces small crystals in the blend. 
These small crystals then form a protective shell around the water droplets and therefore stabilise 
the initial water in oil emulsion which is then used to produce a double emulsion (Frash-Melnik, 
2010).   
But if this technique were applied there would still remain issues as the emulsifiers used for the final 
emulsion are functional proteins  (Dickinson, 2011)  which are not compatible with a low protein 
PKU diet and as such replacements would need to be found. 
If the issue with the emulsifier were solved further problems would need to be overcome, as the 
materials that are generally encapsulated are solubilised in the first water phase. The amino acid 
blend used contains both water soluble and insoluble amino acids and therefore  electrolytes, sugars 
or polysaccharides would have to be added to the final water phase in order to maintain an osmotic 
balance as any osmotic pressure can lead to a shrinkage or swelling of the inner emulsion droplets 
emulsion droplets which can lead to rupture (Dickinson, 2011).  Also the insoluble amino acid 
crystals can physically rupture the droplets (Frash-Melnik, 2010). Once ruptured the negative tasting 
amino acids would be present in the final water phase and no longer be encapsulated and would be 
available to interact with the oral surfaces of the mouth . 
1.4 Viscosity 
Another approach for masking negative flavour attributes is to increase the viscosity of the product 
using a rheological modifier.  This increase in viscosity acts to reduce the rate of diffusion of the 
negative attributes from the bulk into the saliva and onto the taste buds and therefore reduces their 
perception (Sohi, 2004).   
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This approached has already been applied to a PKU product where pectin was added to produce a 
selection of gels of increasing viscosity containing amino acids. These gels were then tested using a 
trained sensory analysis panel which produced favourable results with a reduction of negative taste 
attributes with increasing pectin addition, with a 20mm reduction on a 100mm intensity scale each 
2% increase in pectin (Anders, 2011), figure 1.3.
 
Figure 1.3 Flavour Attribute intensities with increasing viscosity (Anders, 2011). 
This was then transferred to produce a commercial product, thickened by pectin, and the opinions of 
60 consumers were sought, and although some participants liked the concept with 28% of 
participants perceiving an improved flavour over a liquid supplement, 53% did not perceive any 
flavour improvement (Rason, 2011) . In addition some participants did not like the gelatinous texture 
and there was concern about a reduction in convenience as the product required a spoon to eat. 
Therefore the technique was concluded to be unsuccessful. 
1.5 Beads 
Another technology to consider is the encapsulation of the negative flavour components in a 
hydrogel bead. This technology has successfully masked unpleasant bitter tastes, such as 
polyphenolic compounds in the pharmaceutical industry (Stojanovic, 2012) and has been used to 
mask the bitter taste of polypeptides and protein hydrolysates (Mohan, 2015) which are similar to 
amino acids.  There is a wide range of materials that may be encapsulated in addition to water 
soluble materials, with hydrophilic and solid materials such as particles, yeast and bacterial cells 
being encapsulated into the gel matrix (Dordevic, 2015). This ability is important as the amino acid 
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blends required contain both water soluble and insoluble amino acids so the ability to encapsulate 
solid particles is desirable.  
Once produced the beads would be consumed within a suitable carrier or food matrix. Alginate 
beads containing colours and flavours have been successfully added to beverages to provide a novel 
drinking experience. However the integrity of the bead and shelf life of the product can be 
influenced by the matrix and the composition of the bead (Genialab,2005).  
In hydrogel manufacture the material to be encapsulated is mixed with the gelling material and 
extruded through an orifice to form a gel droplet. Once formed the droplet is immediately solidified 
to form a capsule by a physical (cooling, heating) or chemical process, thus encapsulating the 
material. (Dordevic, 2015). It also possible to produce encapsulates by firstly producing an ‘empty’ 
hydrogel which is then placed in a solution of the material, and the material allowed to diffuse into 
the beads. However this technique is limited to water soluble materials. 
Several gelling materials may be used to construct hydrogels, however some pharmaceutical 
materials are not permitted for food use. In food applications hydrogels are generally produced from 
polysaccharides and proteins as they exhibit good technical properties (gelation) and are legally 
permitted in several applications (Dordevic, 2015). As the product is intended for PKU patients the 
use of proteins would not be permitted so a hydrogel would therefore have to be constructed using 
polysaccharides.  
It is possible to produce gels using xanthan and guar gums as the mixture of gums has a synergistic 
effect giving enhanced gelling properties (Draget, 2010) . However they gel on the addition of water 
which would make them unsuitable for producing a hydrogel as  it would be difficult to form a bead. 
Pectin can also produce gels and comes in two main types high and low methylated ester pectins. 
High methylated ester pectins  will only form gels in the presence of high levels of sugar, around 65% 
and a suitably low pH, around 3.4 to 3.2, and the gel is formed by cooling the solution down  (Draget, 
2010). Low methylated ester pectin relies less on the pH and sugar content and more on the 
interaction between the pectin and calcium ions to form gels, but there is a minimum pH (3.0 to 5.0) 
and soluble solids level (10-80%) required for gelatinisation (Draget, 2010). Therefore it would be 
possible to produce hydrogels using pectin, utilising the physical gelatinisation method of high 
methylated pectin or a chemical gelatinisation method of a low methylated method. However both 
require relativity high soluble solids content and a low pH which would not be suitable in 
combination with an amino acid based supplement due to the higher calorie product it would 
produce. 
Another polysaccharide that can be considered for bead manufacture is carrageenan. There are 
three main types of carrageenan, Iota, Kappa and Lambda with the difference depending on the 
position and amount of ester sulphate groups on the galactose units which has an influence on the 
type of gels produced.  Lambda, which contains the highest amount of ester sulphate groups, does 
not form a gel whereas  Kappa which contains the least amount of ester sulphate groups,  once 
dissolved in water at 70oC or greater, will rapidly form strong, rigid gels once cooled in the presence 
of potassium as a gelling agent (Draget, 2010) . Therefore by utilising physical and chemical 
gelatinisation techniques it would be possible to produce a hydrogel using kappa carrageenan.  
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The main polysaccharide used in hydrogel manufacture is alginate which has been used extensively 
in both food and pharmaceutical applications (Bellich, 2011).  Alginate rapidly forms firm gels in a 
calcium solution, which can be easily utilised for producing hydrogels.  Alginate hydrogels have been 
shown to be both physically and chemically stable (Li, 2011) and have been previously used for 
peptide encapsulation (Mohan, 2015), therefore it should be possible to produce amino acid 
containing hydrogels. 
1.6 Alginate Beads 
Alginate is an extract of the marine brown algae and consists of linear, 1-4 linked β-D-Mannuronic 
acid (M unit) and α-L-Guluronic acid (G unit).  The G and M units join together in one of three 
different blocks, GG…, MM… and MG… as seen in figure 1.4, and it is the proportion, distribution and 
length of these blocks which gives alginate gels their properties.  
 
 
Figure 1.4 Alginate  Structure (Somasundaran, 2006) 
 
In alginate, gelling occurs when a cation (usually calcium) falls into the void in the alginate chain 
produced by 2 G units (G Block). These G blocks can further join with other G blocks which gives arise 
to a 3 dimensional network, this is often referred to as the ‘egg box model’ as shown in figure 1.5.  
This reaction requires no pre-heating and rate of gelling and gel strength can be determined by the 
concentration of calcium, temperature and amount of, and length of G units, with the firmest gels 
being generally formed with the highest concentration and longest G blocks in the highest calcium 
concentration. The gels produced by this mechanism can be produced rapidly without any heat and 




Figure 1.5 Alginate ‘Egg Box’ gelling model (Draget, 2010) 
 
To produce hydrogels using alginates, the solution of the encapsulate material and alginate need to 
be exposed to the gelling solution which is usually a calcium solution. This can be achieved by two 
differing techniques; internal setting and diffusion setting. 
 
In internal setting calcium is released within the product by controlling the pH, the solubility of the 
calcium used and using a sequestering agent in order to slowly set the alginate.  An example of this is 
to use a calcium salt in combination with alginate and slowly reduce the pH, thus making the calcium 
soluble and able to gel the alginate (Imeson 2011). As the gelation rate utilising this method is very 
slow it would not lend itself to hydrogel bead formation. 
 
In diffusion gelling the solution of alginate and encapsulate are extruded into a droplet which is 
introduced into the calcium solution. Once in contact with the calcium solution the calcium will 
quickly diffuse into the alginate. At the calcium / alginate interface gelling will occur and once the 
interface is saturated with calcium ions, the interface will then move as the calcium further diffuses 
in to the alginate. This  causes further gelling, until the alginate is completely saturated with calcium 
and is gelled (Imeson, 2011). As this process is a diffusion process it requires a small droplet size, but 
it does offer rapid gelatinisation  
 
 
1.7 Droplet Formation 
The hydrogel beads produced are formed by initially forming a droplet which then combines with 
the gelling material to form the beads.  There are several different ways that droplets can be 
formed, from simply dripping through to more complex methods such as electrostatic extrusion, 
coaxial air flow, vibrating jets and spinning discs depending on the amount of  droplets required and 
the physical properties of  the material (Dordevic, 2015)  
The physical property of the droplets is determined by the Plateau – Rayleigh instabilities and is 
related to surface tension of the liquid. These instabilities explain why the falling stream of liquid 




Figure 1.6 Plateau Raleigh Instability (Vincent, 2014) 
In this model the rate at which the fluid column forms into droplets is determined by perturbations 
in the fluid column. These perturbations are small areas of instability within the column and at a 
certain point the instabilities will become large enough for the column to decay into droplets.  
(Dressen, 2013)  
The time it takes for these perturbations to grow and decay in the column is affected by several 
factors.  The width of the column has a direct effect on the time taken to decay, as a thin column 
cannot withstand the growth of the instabilities as long as a large column.  The width of the column 
is determined by aperture of the nozzle, but also by the viscosity of the fluid. 
 As the liquid falls from the nozzle the diameter of the column decreases as it is stretched. However 
in a more viscous product the perturbations are dampened by the viscosity and therefore the 
column is able to stretch further gaining a smaller diameter before they destabilise the column into 
droplets. This can be seen in the difference between a water column which breaks in around 10cm 
and a honey column which can go over 10m before breaking up (Ball, 2013). Therefore viscous fluids 
can break up into longer columns and produce larger droplets.  
1.8 Diffusion 
 In hydrogels diffusion is an important physical parameter to consider. Diffusion not only controls the 
rate of gelatinisation in carrageenan and alginate hydrogels, but also that ability of the hydrogel to 
retain encapsulated material as there is the capacity for water soluble materials  to diffuse out of the 
hydrogel into the gelling solution (Dordevic, 2015).  
Diffusion is the net movement of molecules from an area of high concentration, i.e. The gelling 
solution to an area of low concentration i.e. the droplet and can be described by Flicks laws. In flicks 
laws the rate of diffusion is referred to as the diffusion flux (J) and is used to determine how fast the 
diffusion occurs. The flux can be defined in a few different ways but is generally described as  the 





Equation 1.0  Diffusion Flux (Callister, 2015) 
 
In Flicks first law, under steady state conditions the diffusion flux is proportional to the 






Where  J= Diffusion Flux mol/m2s-1 
 D = Diffusion co-efficient or diffusivity m2/s 
 x =  Length diffused along (m) 
 ∅=  Concentration (mol/m3)  
 
In order to determine the diffusion flux the diffusion co-efficient is required; fortunately diffusion 





Table 1.2 Diffusion coefficients of amino acids  (Young, 2005) 
 
 
Table 1.3 Diffusion coefficients of minerals (Archer, 1948) 
Mineral D (m-2s)  
Potassium Chloride 1.83 
Calcium Chloride 1.165 
 
1.9 Digestion models 
When new food forms or delivery systems, such as the hydrogels, are developed work is required in 
order to test their effectiveness,  as no matter how good the encapsulate system is at  masking the 
amino acid flavours  they still need to be bioavailable in order for the patients to thrive.   
 
By using  in vivo feeding methods it is possible to obtain very accurate results by feeding the 
hydrogels to humans and or animals and then monitoring and measuring parameters over time (Sun, 
2011).  However although highly accurate, in vivo methods are very time consuming and costly and 
as such would not be practical for the hydrogel study and therefore  an in vitro model is required. 
 
In vitro models are widely used with the food and pharmaceutical industries to model the 
digestibility and release of components under simulated gastrointestinal conditions. Due to the 
physiochemical and physiological complexity of digestion there are several models  available, with 
differing digestion times, ionic composition, temperatures, pH, mechanical stress and enzymes used 
depending on which parts of digestion is being modelled e.g. mouth, stomach, duodenum,  and what 
outcome is desired (Sun, 2011). 
 
One of the most important components in an in vitro model is the enzymes used, with specific 
enzymes used to give maximum digestibility and rate of hydrolysis. The enzymes can be added as a 
biological mixture containing several enzymes, however it is often advantageous to use single 
enzymes as this aids consistency and greater predictability is achieved especially if investigating the 
digestibility of a single nutrient (Coles, 2005).   There are three main enzymes used in digestion 
models, lipases which are generally present in the stomach and pancreas which breakdown lipids 
into fatty acids, proteases which are mainly present in the stomach and small intestine which 
breakdown proteins and polypeptides into amino acids, and amylases which are present in the 
mouth and stomach and are involved in the breakdown of starches into  oligosaccharides and 
monosaccharides (Sun, 2011).  In the digestion of amino acid containing hydrogels the use of 
enzymes is limited if required at all as the components of the hydrogels are not affected by digestive 
enzymes. The hydrogels contain no lipids so there is no requirement for lipase, the amino acids 
present are already elemental so can undergo no further hydrolysis by a protease and the alginate is 
an indigestible polysaccharide and as such will not be broken down by amylase (Brownlee, 2005). 
Amino acid D (m2/s)  







The pH is important factor when considering  in vitro systems as the pH will change depending upon 
which step or steps of the digestion process is being modelled.  In hydrogels, however the pH is 
more critical as the release of encapsulated materials can be determined by the size and shape of 
the hydrogel (Bellich, 2011) which is influenced by the pH.  At lower pH values shrinkage occurs due 
to a decrease in the repulsive charge due to protonation of any free carboxyl groups on the alginate 
molecules, also the calcium ions can dissociate from the chains at a  low pH which allows the 
alginate chains to come closer together (Zeeb, 2015).  This shrinkage leads to a reduction of the 
dimensions of pores within the hydrogel matrix and  can affect the release of particles and diffusion 
from the hydrogel (Zeeb, 2015). 
 
In terms of time and temperature most digestion occurs at 37oC with a time that mimics the typical 
digestion time in humans. However this time is dependent on the particle size of the ‘food’ particles,  
with larger particles moving through the stomach slower than small particles as the size of the 
particles  have to be small enough to pass through the pylorus valve separating the stomach and the 
small intestine (Sun, 2011). 
Therefore it is possible to produce an in vitro digestion model to determine the bioavailability of the 
amino acids within the alginate hydrogel. 
 
1.10 Design of Experiment methodology  
In the design of experiment methodology a systematic approach is used to determine the 
relationship between inputs and outputs so that cause and effect relationships can be (Minitab, 
2015).   
In this model the inputs into the experiment are broken down into factors and levels. A factor is a 
major independent variable, and a level is a subdivision of the factor, for example calcium and 
alginate in the recipe which could have been added at different levels. The factors were the calcium 
and alginate and the different amounts added where the levels  If you have two factors each with 
two levels  it can be expressed as 2x2 or 22 factorial design; where the 2 is the level, and the 
superscript 2 is the factor i.e. #levels#factors.  If we use this example in the calculation it can show how 
many experimental conditions are required, ie 22 = 4 experimental conditions, 25 = 5 factors with 2 
levels = 32 experimental conditions. (Trochim, 2006).  
As the levels for each factor can be continuous rather than discrete it can be possible to produce 
several levels and therefore a large amount of experiments which would not be feasible.  
To reduce the number of experiments down to a more manageable level a two level Plackett 
Burman factorial design method can be used (steele, 2012). Using this method it is possible to vastly 
reduce the number of experiments, but still learn a great deal from the data as it can be possible to 
learn as much from a two level design as a four level design using this method. This is especially true 
when conducting sequential experiments, where the learned outcomes can be fed into future 
experiments (steele, 2012).  
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However the success of a design of experiment model is dependent on the amount of factors and 
levels used, and it is often useful to carryout exploratory experiments in order to help define the 
experimental space (Barry, 2011). In addition centre points can be added to increase the model 
accuracy as it can determine if the data is linear or curvature points. 
1.11 Regression analysis  
Using regression analysis it is possible to understand the relationships between the various factors 
(predictors) and the outcome (response) in the form of a mathematical model. There are different 
types of regression, depending upon whether the predictors and responses are continuous or 
categorical.  When a continuous predictor and response are used both linear and non-linear 
regression models can be used. 
A linear regression model is based around two components and is widely used. As seen in equations 
1.1 and 1.2 below, a deterministic component which is determined by changes in the predictor 
variables, and a stochastic component which is the randomness and unpredictability and explains 
the difference between the expected value and the observed value.  
Equation 1.1  
Response = (constant + predictor) + error 
Equation 1.2 
Response = deterministic + stochastic  
(Frost, 2012)   
For the regression model to function correctly this randomness and unpredictability are critical, as in 
a perfect regression model the deterministic components would explain the relationship so well that 
the difference between the observed and expected values would be solely down to inherent 
randomness. This can be determined by plotting the residuals, or observed errors, as if they have a 
constant spread throughout the range and are not systematically high or low and generally appear 
random, it can be assumed that the observed error is based on stochastic errors only (Frost, 2012).  
As in the design of experiment method it is also useful to undertake preliminary experiments in 
order to know which variables to include in the model.  To help with the model accuracy only three 
predictors should be used (Frost, 2013) and a normal probability plot of the residual completed, as  
the residuals should be normally distributed  to gain the best model (Frost, 2014). 
Non-linear regression models can also be used, and although useful can have several drawbacks as 
they are difficult to set up and often the effect of each predictor has on a response is not often clear. 
Also it is not possible to calculate P values for predictors and it is not always possible to calculate 
confidence intervals (Frost, 2011).  
In both linear and non-linear regression it should also be noted that they are models, and correlation 
does not necessarily mean causation and it is advisable to understand the fundamental causal 
relationship (Frost, 2013). 
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2.0 Methodology 
The experiments were conducted at Nutricia Liverpool, who develop and manufacture protein 
supplements for metabolic disorders .  
2.1 Materials 
Sodium Alginate – Protanal GP5450 supplied by Danisco, Marlborough, UK. 
Calcium Lactate – Analytical grade supplied by Fisher Scientific, St. Helens, UK. 
Calcium Chloride – Analytical grade supplied by Fisher Scientific, St. Helens, UK 
Maltodextrin – DE21 supplied by Cargill, Manchester,  UK 
Sodium chloride – Analytical grade supplied by Fisher Scientific, St. Helens, UK 
Potassium chloride – Analytical grade supplied by Fisher Scientific, St. Helens, UK 
Sodium hydrogen carbonate – Analytical grade supplied by Fisher Scientific , St. Helens, UK 
Xanthan gum – 200 Mesh supplied by Danisco, Marlborough, UK. 
Cherry flavour 96323-33 – Supplied by Givaudan, Milton Keynes UK 
Sucrose – Granulated supplied by Tate and Lyle, London UK 
1M hydrochloric acid – Analytical grade supplied by Fisher Scientific, St. Helens, UK 
Anamix Junior amino acid blend – Supplied by Nutricia Liverpool (composition as shown in table 2) 
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Figure 2.0 Experimental overview 
 
2.2.1 Proof of concept bead manufacture method 
The following method was developed to test the concept of producing an amino acid containing 
lginate bead. 
1. 10g of amino acid mixture was dry blended with 1g alginate for 5 mins.   
















Mg ASPARTATE DIHYD. 1.5 
TRYPTOPHAN 1.2 
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2. 89g of distilled water was weighed into a beaker and the dry blended amino acids and alginate 
blend added whilst mixing with a Silverson L5T high-sheer mixer at 5000rpm, until a homogenous 
mix was produced. 
3 The viscosity of feed was measured using a Anton Paar NCR 200 rheometer at 25oC using a 50mm 
cone and plate measuring system and a sheer rate of 100s-1, (as per method outlined in appendix 2). 
4. 297ml of distilled water was measured and 3g of calcium lactate added in a 500ml beaker and 
stirred until dissolved. 
5. Alginate / amino acid feed was dropped using a 2ml pipette with a 3 mm  aperture from a height 
of 50cm into the an agitated calcium lactate solution. 
6. The beads remained in the solution overnight. 
7. The beads were then removed using a screen and washed with distilled water for 2 minutes, dried 
on blue roll and stored in a 100ml Sterilin jar. 
 
2.2.2 First pilot experiments bead manufacture method 
This method is based upon the proof of concept method but the amounts of amino acids, alginate 
and calcium where varied and the mass of the beads were measured. 
1. The amino acid mixture was dry blended with alginate using the amounts shown in table 2.1  
2.  Distilled water was weighed into a beaker and the dry blend added whilst being mixed using a 
Silverson L5T high sheer mixer at 5000rpm, until mix was homogenous. (Amount of water dependant 
on experiment as shown in table 2.1) . 
3 The viscosity of feed was measured using a Anton Paar NCR 200 rheometer at 25oC using a 50mm 
cone and plate measuring system and a sheer rate of 100s-1, (as per method outlined in appendix 2) 
4.  300ml of calcium chloride solution was prepared in a 500ml beaker using the amounts shown in 
table 2.1. 
5. Alginate / amino acid feed was dropped using a 2ml pipette with a 3 mm  aperture from a height 
of 50cm into the an agitated calcium chloride solution. 
6. The beads remained in the solution overnight. 
7. The beads were then removed using a screen and washed with distilled water for 2 minutes, dried 
on blue roll and stored in a 100ml Sterilin jar. 
8. The beads were randomly selected into batches of 10, weighed. This was repeated twice more 




2.2.3 Second pilot experiments bead manufacture method  
This method was based upon the first pilot method and the amounts of amino acids, alginate and 
calcium were varied but a smaller aperture was used to form the droplets and the bead volume was 
measured. 
1. The amino acid mixture was dry blended with alginate using the amounts shown in table 2.2  
2.  Distilled water was weighed into a beaker and the dry blend added whilst being mixed using a 
Silverson L5T high sheer mixer at 5000rpm, until mix was homogenous. (Amount of water dependant 
on experiment as shown in table 2.2) . 
3 The viscosity of feed was measured using a Anton Paar NCR 200 rheometer at 25oC using a 50mm 
cone and plate measuring system and a sheer rate of 100s-1, (as per method outlined in appendix 2). 
4.  300ml of calcium chloride solution was prepared in a 500ml beaker using the amounts shown in 
table 2.2. 
5. Alginate / amino acid feed was dropped using a 2ml pipette with a 0.4 mm  aperture from a height 
of 50cm into the an agitated calcium chloride solution. 
6. The beads remained in the solution overnight. 
7. The beads were then removed using a screen and washed with distilled water for 2 minutes, dried 
on blue roll and stored in a 100ml Sterilin jar. 
8. The beads were then measured using the liquid dispersion cell of the Mastersizer analyser filled 
with distilled water (as described in appendix 3). 10g of beads were added to the cell and a  
dispersant refractive index of 1.342 (Prakash, 2003) and a suspension refractive index of 1.33 (Hale, 
1973) used analysis.   The volume weighted mean (equation 2.0) was calculated automatically by the 
Mastersizer software. 
Equation 2.0 




Where d = diameters of the spheres under measurement  
(Malvern, 2010) 
 
2.2.4 Third pilot and standard bead manufacture method 
This method was based upon the second pilot method and the amounts of amino acids, alginate and 
calcium were varied and in addition to the smaller aperture the amino acid blend was milled to a 
smaller particle size. This method was the standard method used in all subsequent experiments. 
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1.  Annamix Jnr amino acid mixture was milled using a Retsch ZM100 bench top mill (18,000 rpm, 
0.5mm ring). To avoid excessive heating during milling only 500g of amino acid was milled at one 
time. 
2. The particle size pre and post milling was measured using the powder cell on the  Mastersizer 
analyser (as described in appendix 3) 
3. Amino acid mixture was dry blended with alginate, using the amounts shown in tables 2.4, 2.5 and 
2,6. 
4. Distilled water was weighted into a beaker and the dry blend added whilst mixing using a Silverson 
L5T high sheer mixer at 5000rpm, until mix was homogenous.  Amount of water dependant on 
experiment as shown in tables 2.4, 2.5 and 2.6. 
5.  300ml of calcium chloride solution was prepared in a 500ml beaker using the amounts shown in 
tables 2.4, 2.5 and 2.6. 
6. Alginate / amino acid feed was dropped using a 2ml pipette with a 0.4 mm  aperture from a height 
of 50cm into the an agitated calcium chloride solution. 
7. The beads remained in the solution for a fixed amount of time, dependant on the experiment. 
8. The beads were then removed using a screen and washed with distilled water for 2 minutes, dried 
on blue roll and stored in a 100ml Sterilin jar. 
9 The beads were then measured using the liquid dispersion cell of the Mastersizer analyser filled 
with distilled water (as described in appendix 3). 10g of beads were added to the cell with a 
dispersant refractive index of 1.342 (Prakash, 2003) and a suspension refractive index of 1.33 (Hale, 
1973) used for analysis.   The volume weighted mean (equation 2.0) was calculated automatically by 
the Mastersizer software. 
2.2.5 Digestion model 
In order to determine if the amino acid contained in the beads was available for digestion it was 
necessary to model the digestion. Although utilising an in vivo method would have provided the 
most accurate results these methods are time consuming and expensive (Sun, 2011), therefore an in 
vitro model was utilised. 
There were several in vitro models available and in order to decide which model was the most 
suitable it was necessary to examine the composition of the beads and from this determine which 
digestive enzymes would be the most suitable. The beads are composed of amino acids, calcium, 
chloride and alginate.  Alginate is an indigestible polysaccharide and is a source of dietary fibre and 
as such it is not broken down by amylase (Brownlee, 2005).Amino acids are the basis of protein and 
cannot be further broken down by protease and there is no lipid contained in the beads. Therefore 
there is no requirement for lipase so the use of digestive enzymes within the in vitro model was not 
required. 
The pH and ionic concentrations are an important part of a model, as the pH and ionic composition 
within the digestive tract can vary from acidic conditions within the stomach to more neutral 
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conditions in the intestines (Sun, 2011). Therefore the digestion was modelled in two stages, with a 
more acidic ‘stomach’ phase containing a simulated gastric solution, and an intestinal phase at a 
higher pH with a simulated intestinal solution. 
The time and temperature of digestion were also considered with digestion modelled at 37oC to 
simulate body temperature (Rayment, 2009). The digestion time can vary depending upon the age, 
condition, sex, type of food and time of the day (Sun, 2011). For the in vitro model a stomach 
digestion time of one and half hours and an intestinal digestion time of 2 hours was used (Rayment, 
2009). 
The method below was used to perform an in vitro digestion model. 
1. The beads were manufactured by the standard method as described in 2.2.4, with 10% (w/w) 
amino acid and 3% (w/w) alginate feed being dropped into a 30% (w/w) calcium chloride solution 
and left for 1 minute.  A sample of the beads was tested for nitrogen content (as per Dumas method 
described in Appendix 1). 
2. A simulated gastric solution containing 2.86g NaCl, 0.865g KCl and 0.4g CaCl2 per litre (Rayment, 
2009) and a simulated intestinal solution containing 6.5g NaCl, 0.835g KCl, 0.22g CaCl2 and 1.386g 
NaHCO3 per litre (Rayment, 2009) were prepared. 
3.  200ml of simulated gastric solution was heated to, and held at 37oC using a Stuart SD162 
temperature regulating hot plate. Agitation was provided by a magnetic stirrer. 
4. 10g of amino acid alginate bead was added, after 10 minutes 1M hydrochloric acid was slowly 
added until pH 2.0 was reached.  The solution was agitated for 90 minutes. 
5. After 90 minutes the beads were removed from the solution and placed into 200ml of simulated 
intestinal solution at 37oC with a magnetic stirrer providing agitation. After 120 minutes in the 
solution, the beads were removed and rinsed in distilled water, dried and then analysed for nitrogen 
content using the Dumas method. 
6. The nitrogen content of the beads before and after digestion was measured in order to determine 
the amount of amino acids remaining within the beads. 
 
2.2.6 Carrier preparation 
This method was used to prepare the carrier for the placebo and active beads in the sensory testing. 
1. 0.1g Xanthan gum and 120g sucrose were dry blended together. 
2.  79.7g distilled water was weighed into a 300ml beaker  and the  xanthan / sucrose blend added 
whilst agitating using a Silverson L5T high sheer mixer at 5000rpm, until mix was homogenous  
3. The  cherry flavour was then added and  the beaker zeroed on the scale. 
4. The beaker was then heated on the Stuart SD162 temperature regulating hot plate until all the 
sucrose had dissolved. Agitation was provided by a magnetic stirrer. 
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5. The beaker was returned to scale and water added until the scaled returned to zero, to replace 
any condensate loss. 
6.  The carrier was stored overnight to cool and for all entrapped air to be released. 
2.2.7 Nutricia Methods 
Nitrogen determination Dumas method     Appendix 1 
Viscosity measurement       Appendix 2 
Particle size measurement using laser particle diffraction  Appendix 3 
Inductively coupled plasma spectrophotometry     Appendix 4 
Chloride analysis       Appendix 5 
Aw analysis        Appendix 6 
 
2.3 Proof of concept experiment 
In order to make the alginate beads the diffusion setting method was used. In this method, the 
alginate solution was dropped using a pipette into a bath of gelling solution of  Ca2+, allowing the 
calcium to diffuse into the droplet causing rapid gelatinisation to produce a bead. Several methods 
exist for producing droplets, but as the viscosity of the material to form the droplets is relatively low 
and there were no requirements for a large amount of beads to be produced, the simple dropping 
method proved the most viable as it was simple to prepare and required no specialist equipment. 
To produce the alginate beads a 0.6 to 3% sodium alginate solution and a 0.05 to 1.5 M calcium 
chloride gelling solution can be used (Dordevic, 2015). In the initial experiment a solution of 1% 
sodium alginate (w/w) and 10% (w/w) Anamix Junior amino acid mixture was used to manufacture 
the beads as per the method described in 2.1.1. 
Several amino acid mixtures were available for the treatment of PKU but for the experiments the 
Anamix Junior amino acid mixture, as shown in Table 2, was chosen as it contained higher levels of 
amino acids with positive flavour attributes compared to other PKU amino acid blends. The level of 
alginate and amino acids were kept to a minimum as it was important to maintain a relatively low 
feed viscosity in order to form droplets.  
Calcium lactate was initially chosen over calcium chloride for the gelling solution, as calcium chloride 
can have a salty taste due to the chloride ions present. The beads remained in the solution with light 
agitation overnight and were harvested from the solution using a fine screen and examined visually 
for bead integrity. On examining the beads, it was noted that although a roughly-spherical bead was 




2.4 First pilot experiments 
In these experiments, the beads were manufactured using the initial bead method but the levels of 
amino acids and calcium varied with a constant level of alginate. In addition, the calcium source was 
changed from calcium lactate to calcium chloride as calcium chloride contains a higher amount of 
calcium and is more soluble; 36% by mass calcium, 102g/100ml solubility, compared to 18% by mass 
calcium, 7.9g/100ml solubility. The amounts of amino acid blend used were 10, 20 and 30% (w/w) 
which were dispersed into a 1% (w/w) alginate solution and the viscosity measured as before. This 
mixture was then dropped into 1, 2 and 3% calcium chloride solution.  The experiment is outlined in 
table 2.1 and the beads manufactured as per the method described in 2.1.2 
 
Table 2.1 First pilot experimental outline 
Calcium Chloride 
solution (% w/w) 
Amino Acid blend  
(g/100g feed solution) 
Alginate 
 (g/100g feed solution) 
1 10 1 
2 10 1 
3 10 1 
1 20 1 
2 20 1 
3 20 1 
1 10 1 
2 20 1 
3 30 1 
 
Initially it was intended for the beads  to be characterised by laser particle diffraction in order to 
determine the size, however the measuring cell has a maximum diameter of 2mm and the majority 
of the beads produced where visibly larger than this. Therefore the beads were characterised by 
mass, with the mass of 10 randomly selected beads measured. This was repeated three times and an 
average taken.  
 
2.5 Second pilot experiments 
In these experiments the beads were manufactured as in experiment 2.1, but in addition to varying 
the calcium and amino acids the alginate content was varied with 1, 2 and 3% (w/w) levels being 
used. The experiments are outlined in table 2.2 and the beads were manufactured as per the 








Table 2.2  Second pilot experimental outline 
 
 
As the beads produced in experiment 2.1 where too large, being greater than 2mm in diameter, the 
aperture of the pipette was reduced from 3mm to 0.4mm. The size of the bead is determined by the 
size of the droplet which can be influenced by several factors, one of which is diameter of the 
aperture as this affects the diameter of the initial liquid column that will form the droplet (Dressen, 
2013).   
 As before the amino acids were dispersed into the alginate solution, however it was not possible to 
produce high amino acid and alginate combinations as the higher viscosity alginate solutions meant 
it was not possible to homogenously disperse all the amino acids and a lumpy dispersion was 
produced.  Also, some amino acid/alginate dispersions, which even though homogenous, produced 
high viscosities which produced elongated strings instead of beads. 
Calcium chloride 
solution (% w/w) 
Amino acid blend  
(g/100g feed solution) 
Alginate 
 (g/100g feed solution) 
1 10 1 
2 10 1 
3 10 1 
1 20 1 
2 20 1 
3 20 1 
1 30 1 
2 30 1 
3 30 1 
1 10 2 
2 10 2 
3 10 2 
1 20 2 
2 20 2 
3 20 2 
1 30 2 
2 30 2 
3 30 2 
1 10 3 
2 10 3 
3 10 3 
1 20 3 
2 20 3 
3 20 3 
1 30 3 
2 30 3 
3 30 3 
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Laser particle diffraction was then used to characterise the bead size using a Mastersizer  produced 
by Malvern Technologies using the liquid dispersion cell with distilled water as the carrier and the 
method outlined in appendix 3.  
In order to determine the amino acid recovery the nitrogen content of beads was used as a proxy 
measurement. The Dumas method was used in preference to the Kjeldhal method as it is a rapid 
method and requires no harmful or toxic reagents to be used (Francini, 2003) and was carried out 
using the Nutricia method as described in Appendix 1. The recovery was then found by calculating 
the theoretical total amount of nitrogen from the amino acids present as shown in table 2.3 and 
then comparing it to the nitrogen found by analysis. 
Table 2.3 – Total Nitrogen in bead calculation 
Amino Acid in blend % Nitrogen content * Nitrogen / 100g 
ALANINE 13.65 15.72 2.146 
GLYCINE 13.10 18.65 2.443 
GLUTAMINE 8.65 19.17 1.660 
TYROSINE 7.60 7.72 0.587 
THREONINE 7.20 11.76 0.847 
LEUCINE 6.50 10.68 0.695 
PROLINE 6.50 12.17 0.791 
CYSTINE 5.45 11.66 0.635 
ARGININE 5.00 32.16 1.608 
VALINE 4.80 11.96 0.574 
ISO-LEUCINE 3.85 10.68 0.412 
LYSINE ACETATE 7.45 13.58 1.012 
SERINE 3.43 13.33 0.458 
METHIONINE 2.10 9.39 0.197 
HISTIDINE 2.00 27.09 0.542 
Mg ASPARTATE DIHYD. 1.50 8.63 0.129 
TRYPTOPHAN 1.20 13.72 0.165 
  
Total Nitrogen / 
100g amino acid 
(g) 
14.899 
* (FAO, 2002) 
 
10% Amino acid bead = 
14.899
100
× 10 = 1.489g Nitrogen 
20% Amino acid bead = 
14.899
100
× 20 = 2.979g Nitrogen 
30% Amino acid bead = 
14.899
100
× 30 = 4.469g Nitrogen 





× 100 = 24.83% recovery 
 
2.6 Third pilot experiment  
In these experiments beads were produced in the same manner as in 2.4 with a variance in the 
calcium, alginate and amino acid content. However, combinations that produced an alginate 
solutions that were too thick to form, or produced strings instead of beads, were omitted. The 
experiments are outlined in table 2.4 below and the beads manufactured as per the method 
described in 2.1.4. This method of bead manufacture became the standard way in which all the 
beads were manufactured for subsequent experiments. 
Table 2.4  Third pilot experimental outline 
 
 
It was noted in experiment 2.1 that large particles of amino acid mix were present in the feed 
solution which lead to blockages in the 0.4 mm aperture pipette when forming the droplets and also 
may have led to poor homogeneity and possibly the poor recovery. 
In order to remove these large crystals, the amino acid blend was milled using a Retsch ZM100 
bench top centrifugal mill and the particle size measured for comparison using the Mastersizer  
produced by Malvern Technologies using the powder dispersion cell. 
The beads produced were then characterised for size by laser particle diffraction and nitrogen 
content by the Dumas method.  
 
2.7 First design of experiment 
After completing the pilot experiments to establish the methodology and the experimental 
parameters it was decided to investigate how these different parameters affect the bead and 
therefore a design of experiment methodology was applied. 
Calcium Chloride 
solution (% w/w) 
Amino Acid blend 
(g/100g feed solution) 
Alginate (g/100g 
feed solution) 
1 10 1 
2 10 1 
3 10 1 
1 20 1 
2 20 1 
3 20 1 
1 30 1 
2 30 1 
3 30 1 
1 10 2 
2 10 2 
3 10 2 
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The experiments conducted are outlined in table 2.5 below , and the beads were manufactured as 
per the method described in 2.1.4. 
Table 2.5  First design of experiment outline 
Alginate 
(g/100g in Feed) 
Calcium chloride 
 solution (% w/w) 
Time (mins) 
1.0 3 20.0 
1.0 1 5.0 
2.0 3 20.0 
1.5 2 12.5 
2.0 3 5.0 
2.0 1 5.0 
2.0 3 5.0 
1.0 3 20.0 
2.0 1 20.0 
1.0 1 20.0 
1.0 3 5.0 
2.0 1 20.0 
1.0 1 5.0 
 
Once the beads were produced they were analysed for their nitrogen content to determine the 
amino acid recovery which was fed back into the model as an output and used to produce a main 
effects plot and a standard effects chart. 
From this data it appeared that all the factors had an effect on the recovery, but the recovery levels 
were still sub-optimal as they were less than 80 percent of the added level. Therefore, it was 
decided to work out the relative rates of diffusion for a selection of amino acids to compare to the 
calcium using Flick’s first law of diffusion (equation 1.0) , as there needed to be adequate time for 
the calcium to diffuse and set the alginate without the amino acids diffusing out of the bead. 
 





Where:  ∆∅ = Concentration gradient (mol/m3) 
∆ 𝑥 = Lengh (m) i.e. Radius of a bead (determined from the volume-weighted mean by laser        




 𝐷 = Diffusion Co-efficient / diffusivity (m2/s) 
 𝐽 = Diffusion flow mol/m2s-1 
 
∴ for  Alanine in a 10% (w/w) amino acid solution, where 𝐷= 8.589 m2/s (Young 2005) 
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𝐽 = −2.51 × 106 mol/m2s-1 
∴ for  Glycine in 10% (w/w) amino acid solution, where 𝐷= 10 m2/s (Young 2005) 




𝐽 = −3.390 × 106 mol/m2s-1 
 
 
∴ for  a 1% (w/w) Calcium  chloride solution , where 𝐷= 1.165 m2/s (Archer, 1948) 




𝐽 = −2.045 × 109 mol/m2s-1 
 
∴ for  a 10% Calcium solution , where 𝐷= 1.165 m2/s (Archer, 1948) 


















2.8 Second design of experiment 
In these experiments a Plackett Burman factorial design was conducted with 3 factors of 2 levels 
with centre points as in the first experiment. However, in this second experiment the values for the 
levels were adjusted based on the outcomes from the first experiment. The experimental outline is 
shown in table 2.6 below and the beads where manufactured as per the method described in 2.1.4 
Table 2.6  Second  design of experiment outline 
Calcium chloride 
solution (% w/w) 
Alginate 
(g/100g feed solution) 
Time (mins) 
10 3 4.0 
10 3 1.0 
30 1 1.0 
20 2 2.5 
10 1 1.0 
30 1 4.0 
10 1 4.0 
30 1 4.0 
30 3 1.0 
30 3 4.0 
10 1 1.0 
10 3 4.0 
30 3 1.0 
 
The beads were analysed for their nitrogen content to determine their amino acid recovery which 
was fed back into the model as an output. This data was then used to produce a main effects plot 
and a standard effect chart as in experiment 1.  
The data was then subjected to a regression analysis. There are several different type of regression 
analysis available, but as the both the predictors and responses used were continuous and non-
categorical then a regression model was used (Frost, 2012).  A normal plot was then produced and it 
was determined that linear regression would be used. 
The residuals were then plotted.  As the residuals had a constant spread throughout the range and 
were not systematically high or low and generally appeared random, and therefore it was assumed 
that the observed error was based on randomness and unpredictability only (Frost, 2012).  
The regression modelling was then carried out and the multiple linear regression equation was 
calculated and for each predictor the coefficient, standard error of the coefficient, T value, P value, R 
squared and adjusted R squared values were calculated.  
In order to test for multicollinearity, where predictors correlate to each other, a variance inflation 




2.9 Food Safety 
Before permitting the beads to be consumed by colleagues it was necessary to determine if the 
composition was safe. The composition of the beads was known in terms of alginate and amino acid 
but the calcium and chloride content from the diffusion was unknown. Therefore the calcium 
content was analysed using inductively coupled plasma spectrophotometry and chloride using a 926 
Korning chloride analyser as per the Nutricia methods described in appendix 5 and 6. The levels were 
then normalised for dosage (10% w/w beads in a sucrose solution) and compared to the daily 
reference intakes outlined by the UK Department of Health. 
 
2.11 Carrier 
For the beads to be consumed a liquid carrier was needed.  The liquid carrier needed to be of 
sufficient viscosity to suspend the beads to aid consumption and homogeneity. Generally the 
palatability of a carrier can be increased by making the carrier sweet (Rolls, 1982) with the use of 
fruit flavours and a syrupy texture (Pharmacy, 2015) .Therefore a thickened sucrose solution with a 
fruit flavour was used. 
In order to avoid moisture movement from the beads to the sucrose solution the aw needed to be 
considered and matched to the aw of the beads. This is because the rate of moisture migration is 
proportional to the difference in aw, with water migrating from an area of high aw to an area of low 
aw until an equilibrium is reached (Skilcast, 2011) . The aw of the beads was measured using a Sprint 
TH-500 aw analyser as per the Nutricia method described in appendix 7 and found to be 0.955, 
therefore a  60% (w/w) sucrose solution with an aw of 0.95 was produced and the final composition 
can be seen in table 2.7 below  and manufactured as per the method described in 2.1.6. 
Table 2.7 Composition of thickened sucrose carrier  
 % w/w Supplier 
Xanthan gum 200 mesh 0.05 Danisco, Marlborough, UK 
Cherry flavour 96323-33 0.10 Givaudan , Milton Keynes, UK 
Sucrose  60.00 Tate and Lyle, London, UK 
Water 39.85 Distilled 
 
2.12 Sensory methods 
To determine the effectiveness of the flavour masking a difference test was undertaken with the 
amino acid beads tested alongside a blank placebo bead.  There are generally three types of 
difference testing available, a paired comparison test, a duo-trio test and a triangle test (Stone, 
2012) . The duo-trio test is generally used for products that have a relatively intense taste and 
odours, and the pair comparison test is recommended when there is limited product availability or 
the product characteristics require a limited exposure due to strong flavours or where excessive 
consumption would not be recommended (Stone, 2012). As the amino acid beads did not have an 
intense taste , strong flavour and can be readily consumed a triangle test was carried out. 
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To run the test a placebo was produced substituting the amino acid blend for a maltodextrin with 
the feed compositions of the placebo and actives shown below in Table 2.8 
Table 2.8 bead feed composition. 
Placebo Composition 
 % w/w Suppier 
Maltodextrin, DE21 10 Cargil, Manchester, UK 
Alginate protanal GP5450 3 Danisco, Marlborough, UK 
Distilled water 87  
 
Active composition 
 % w/w Suppier 
Milled amino acid 10 Nutricia UK 
Alginate protanal GP5450 3 Danisco UK 
Distilled water 87  
 
Beads were then manufactured as per the method described in 2.1.4, with the maltodextrin 
replacing the amino acid blend in the placebo. 
The beads were then dispersed into the carrier solution (composition as per table 2.7) to produce a 
10g bead / 90g carrier dispersion.  It was evident that there was a visual difference between the 
placebo and active beads, even though the beads were of similar size (figure 2.2). 
 
Figure 2.1 Photograph of placebo and active beads 
The samples were presented in lidded cups to be consumed with a straw (figure 2.2) to prevent the 




Figure 2.2 Photograph of lidded sample cups. 
The cups were then coded, with active cups coded 471 and 895, and placebo cups coded 279 and 
794 Three cups were presented to the panellists (figure 2.4), with two cups containing the active and 
one the placebo, or two cups containing the placebo and one the active, and the panellists asked to 
decide which of the three samples was different. The panellists were also provided with a consent 
form and product information sheet. 
  
 
Figure 2.3 Photograph of triangle test cups 
At the end of the test, a tally of correct answers, where the different sample was identified, and 
incorrect answers was made to determine if the number of correct answers was significant. The 
amount of correct answers required in order to determine that the sample was different depended 
on the confidence interval required. The standard that Nutricia works to is a 95% confidence 
interval, and as such the amount of correct answers per total number of panellists required is shown 






Table 2.9 Minimum number of correct answers to establish significance   
















The panel contained 12 participants so for a significant difference 8 or more panellists were required 
to correctly identify the different sample. 
When completing the triangle test it was possible to either use a selection of employees or use the 
Nutricia trained panel.  For the trial the Nutricia trained panel was used as the  panel is more 
accurate and can produce reproducible reliable data when compared to a panel consisting of normal 
employees (Lerma, 2013). This is because in order to become a member of the trained panel testing 
is given to assess the potential panellists’ natural ability which is then enhanced by training over 





3.0 Experimental Results 
3.1 Proof of concept experiment  
 
Figure 3.0 Photograph of beads produced in initial experiment.  
3.2 First pilot experiments 





































1 10 1 0.1980 0.1940 0.2149 0.202 0.108 0.144 
2 10 1 0.2270 0.2238 0.2529 0.234 0.015 0.144 
3 10 1 0.2720 0.2810 0.2614 0.271 0.009 0.144 
1 20 1 0.2870 0.2593 0.2225 0.256 0.325 0.229 
2 20 1 0.2720 0.2566 0.2728 0.267 0.009 0.229 
3 20 1 0.2750 0.2741 0.2538 0.267 0.012 0.229 
1 30 1 0.2960 0.3278 0.3277 0.317 0.120 0.460 
2 30 1 0.3000 0.3443 0.2858 0.310 0.030 0.460 












3.3 Second pilot experiments 


























1 10 1 0.146 0.21 14.10 1245 
2 10 1 0.146 0.21 14.10 1165 
3 10 1 0.146 0.19 12.76 1166 
1 20 1 0.230 0.20 6.71 894 
2 20 1 0.230 0.19 6.38 1062 
3 20 1 0.230 0.21 7.05 1039 
1 30 1 0.469 0.21 4.70 1137 
2 30 1 0.469 0.20 4.47 1055 
3 30 1 0.469 0.19 4.39 1036 
1 10 2 0.901 0.20 13.43 952 
2 10 2 0.901 0.21 14.10 1137 
3 10 2 0.901 0.21 14.71 852 
1 20 2 1.452 - - Poor beads 
2 20 2 1.452 - - Poor beads 
3 20 2 1.452 - - Poor beads 
1 30 2 1.705 - - Poor beads 
2 30 2 1.705 - - Poor beads 
3 30 2 1.705 - - Poor beads 
1 10 3 2.363 - - Too thick 
2 10 3 2.363 - - Too thick 
3 10 3 2.363 - - Too thick 
1 20 3 4.443 - - Too thick 
2 20 3 4.443 - - Too thick 
3 20 3 4.443 - - Too thick 
1 30 3 Lumpy - - Too thick 
2 30 3 Lumpy - - Too thick 
3 30 3 Lumpy - - Too thick 
 Elongated Beads  
 
 
Figure 3.1 Photograph of elongated strings / Poor beads 
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3.4 Third pilot experiment 
Amino Acid Base powder (Volume weighted mean) 
Before Retsch milling = 0.145mm 
After Retch milling = 0.077mm 




















1 10 1 0.37 24.84 1281 
2 10 1 0.32 21.48 1248 
3 10 1 0.21 14.10 1100 
1 20 1 0.53 26.23 1272 
2 20 1 0.45 22.27 1328 
3 20 1 0.75 37.12 1326 
1 30 1 0.81 26.47 1330 
2 30 1 0.96 31.37 1349 
3 30 1 0.67 21.89 1375 
1 10 2 0.56 37.63 1305 
2 10 2 0.47 31.68 1308 
3 10 2 0.47 31.68 1313 
 
 
3.5 1st design of experiment 










1.0 3 20.0 42.70 
1.0 1 5.0 47.20 
2.0 3 20.0 29.60 
1.5 2 12.5 42.10 
2.0 3 5.0 38.10 
2.0 1 5.0 38.80 
2.0 3 5.0 34.20 
1.0 3 20.0 42.10 
2.0 1 20.0 34.80 
1.0 1 20.0 46.00 
1.0 3 5.0 40.13 
2.0 1 20.0 39.47 




























Main Effects Plot for % rec
Data Means
  
Figure 3.2  Main effects plot for factors in experiment 1, Y axis is %  amino acid recovery, X axis are 












Pareto Chart of the Standardized Effects
(response is % rec, Alpha = 0.05)
 
Figure 3.3 Pareto chart for % recovery of amino acids showing the standardised effects for 
experiment 2  
 
3.6 2nd design of experiment 









Time (mins) Amino acid 
recovery (%) 
10 3 4.0 66.40 
10 3 1.0 71.70 
30 1 1.0 63.15 
20 2 2.5 49.34 
10 1 1.0 60.52 
30 1 4.0 41.40 
10 1 4.0 30.92 
30 1 4.0 45.39 
30 3 1.0 83.50 
30 3 4.0 63.15 
10 1 1.0 52.60 
10 3 4.0 53.28 

























Main Effects Plot for % rec
Data Means
 
Figure 3.4  Main effects plot for factors for second experiment,  were Y axis is %  amino acid 

























Pareto Chart of the Standardized Effects


























(response is % rec)
 
















(response is % rec)
 
Figure 3.7 Residual Plots for % amino acid recovery for the second experiments. 
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Table 3.5 Regression Analysis 
The regression equation is 
% rec = 46.6 + 0.329 Calcium + 10.2 Alginate - 6.07 Time 
 
Predictor Coef SE Coef T P VIF 
Constant 46.638 5.705 8.17  0.000  
Calcium 0.3288 0.1668 1.97 0.080 1.000 
Alginate 10.194 1.668 6.11 0.000 1.000 
Time -6.067 1.112 -5.46  0.000  1.000 
 
S = 5.77756   R-Sq = 88.8%   R-Sq(adj) = 85.0% 
 
3.7 Digestion Modelling 
Table 3.6 Amino Acid recovery before and after in vitro digestion model 
 Nitrogen (g/100g bead) % recovery (w/w) 
Bead prior digestion 1.17 78.57 
Bead post digestion 0.12 8.06 
 
Equation 3.1  Amino acid digestion 
Amino acid digested =   (nitrogen prior digestion − nitrogen post digestion) × conversion factor 
Conversation factor = 6.75 (Pritchard, 1995) 
Amino acid digested =  (1.17 − 0.12) × 6.75 = 7.05g amino acid digested per 10g amino acid 
containing bead. 
 
3.8 food safety 
Table 3.7 Bead calcium and chloride content compared to Department of Health dietary reference 
values 
 mg/100g bead mg/10g bead dose DRV *(mg) Diff (mg) 
Calcium  2346 234.6 700 -465.4 
Chloride   1140 114.0 1,600 -1486 
 
*Dietary reference value age 19-50 ( Acheson, 2013)  
3.9 Sensory 
Table 3.8 Results from triangle test comparing active amino acid containing beads against 




Taste order Sample 
chosen 
Correct Comments 
1 794,279,895 Placebo, 
placebo  active 
Active Yes odd sample less sweet 
2 471,279,794 Active, placebo, 
placebo 
Active Yes sweeter stronger flavour 
3 895,794,471 Active, placebo, 
active 
Placebo Yes Slight difference in taste and 
aftertaste. 
4 471,895,279  Active, active, 
placebo 
Active No Slightly stronger taste. 
5 471,279,895 Active, placebo, 
active 
Active No stronger taste 
6 794,895,279 Placebo, active, 
placebo 
Placebo No 794 is less concentrated and more 
mildly flavoured 
7 895,471,794 Active, active, 
placebo 
Active No Appeared to be less sweeter than 
the other two and less lumpy 
8 279,895,471 Placebo, active, 
active 
Active No It tastes more medicinal, like cherry 
flavoured amoxycillin 
9 279,794,471 Placebo, 
placebo, active 
Active Yes a bit tangy 
10 794,471,895 Placebo, active, 
active 
Placebo Yes slightly moe sweet/almond 
11 895,794,279 Active, placebo, 
placebo 
Placebo No  
12 279,471,794 Placebo, active, 
placebo 
Active Yes appears more concentrated 
 
Number of panellists correctly identifying different sample = 6 
Number of panellists incorrectly identifying different sample = 6 







The experiments can be characterised into four stages. In the first stage the experiments were 
concerned with the development of the bead and optimising the method of manufacture. The 
second stage experiments explored which factors affected the bead in terms of the retention of 
encapsulated amino acids. In the third stage the digestibility of the bead was investigated and finally 
in the fourth stage the sensory properties of the beads were examined. 
 
4.2 Bead manufacture development 
4.2.1 Proof of concept experiment 
The initial experiment was carried out in order to test the concept of encapsulating an amino acid 
blend within an alginate hydrogel.  Although the method of manufacture was crude, beads were 
produced and the amino acids were successfully encapsulated in the bead (figure 3.0). However the 
beads were large and soft to the touch.  Initially the softness of the beads was attributed to the low 
calcium content and low solubility of calcium lactate, producing reduced calcium content in the 
gelling solution. However 3% calcium lactate would produce 0.54g calcium per 100ml, which is 
below the maximum solubility of calcium lactate (7.9g/100ml) and  above the amount of calcium 
that would be available using a calcium chloride at the recommended level of 0.05M  (0.0209g / 
100ml) (Dordevic, 2015) . Therefore sufficient calcium was available to firmly gel the alginate, 
however the lactate can act as a chelating agent removing the calcium from the junction zones thus 
reducing the amount of cross linking and leading to a reduction in gel strength and soft beads 
(Rehm, 2009).Hence it was decided to use the calcium chloride instead. 
 
4.2.2 First pilot experiment 
In these experiments the amount of amino acid blend and the calcium chloride content were varied 
and the concentration of alginate remained constant as shown in table 3.0 . The beads produced 
were firmer to the touch than those produced in the initial experiment. This was due to the gelling 
solution being changed from a calcium lactate to a calcium chloride solution. By changing the 
calcium source not only was there an increase in the calcium available but there was no chelation 
affect from the lactate (Rehm, 2009).    
The feed viscosities for each amino acid level were the same. This was due to the amino acid / 
alginate feed being produced in bulk which was dropped into the calcium gelling solution. As the 
feed viscosity was measured prior to being introduced into the calcium gelling solution, the level of 
calcium would have no effect on the feed viscosity. 
When the amount of amino acid was increased there was an increase in the feed viscosity due to an 
increase in the alginate concentration as the water was displaced by the amino acid. As the viscosity 
increased there was an increase in the bead mass this is shown in figure 4.0. Although the regression 




Figure 4.0 Effect of feed viscosity on bead weight 
Therefore outlier analysis was undertaken using an r11 Dixon test that showed that the 0.444g mass 
was an outlier (figure 4.1).    
 
Figure 4.1 Dixon r11 Outlier plot  
 The Dixons outlier analysis was used as the sample size was low and one value was suspected as 




















Effect of feed visocisty on bead weight
R-Sq = 63.5%
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calculated to produce a R2 of 73.7, which although is larger is still quite low. This may be due to the 
small number of data points recorded. 
The increase in bead mass can be directly related to the mass of the drop that formed therefore the 
increase in viscosity was producing heavier droplets. This may be due to a damping effect, as the 
liquid leaves the aperture it forms a column inside this column natural instability waves form which 
eventually build up and lead to the disintegration of the column which due to surface tension forms 
the droplet.  As the viscosity was increased the internal instability waves were dampened and the 
column grew larger before disintegrating and therefore a larger droplet was formed (Ball, 2013). The 
difference in bead weight could also be attributed to the difference in density, as the higher viscosity 
feed has an increased amino acid component thus a higher density, and would have a larger weight 
for the same size bead. Therefore measuring the weight and inferring a bead size was incorrect and 
measuring the size of the bead would have been preferred, however this was not possible due to the 
bead size being larger than the 2mm aperture of the Mastersizer measurement cell.  
In addition to the beads being too large for size characterisation, the beads being larger than 2mm 
was not ideal for digestion as the particle size will affect the residence in the stomach. For liquids 
containing particles between 1mm and 2 mm in diameter the liquid and particles pass through the 
stomach relatively quickly through the pyloric opening. However if the particle size is larger than 
2mm then they are too large to pass through the pyloric opening and will be ground down by 
contractions of the stomach with any larger particles remaining having to wait until the stomach 
completely empties (Kong, 2008).  This leads to a longer residence time within the stomach and can 
cause bloating and nausea (Lunenfield, 2007). 
In the 10 and 20% amino acid beads the calcium content of the gelling solution had no effect on the 
mass of the beads. In the 30% amino acid beads there was an increase in bead mass at 3% calcium; 
however this value was shown to be an outlier. 
 
4.2.3 Second pilot experiment 
In this experiment the scope was increased to include variations in the alginate content in addition 
to the amino acids and the calcium chloride as shown in table 3.1.  As the droplets were too large in 
the previous experiment, a smaller aperture was used to produce smaller droplets. A smaller 
aperture produces smaller droplets due to its effect on the size of the initial fluid column produced. 
As previously discussed inside the fluid column instability waves are formed, however as the column 
was now narrower it was less robust to the instabilities and therefore disintegrated earlier to 
produce smaller droplets (Ball, 2013). The smaller aperture produced beads with diameters less than 
2mm thus it was possible to measure the beads size and distribution and determine the volume 
weighted mean diameter, D[4,3] . The volume weighted mean was calculated as it showed which 
particle sizes made up the majority of the sample, Figure 4.2 (Malvern, 2012). 
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Fig 4.2 Example of particle size distribution (Malvern, 2012) 
 
When the amount of alginate increased, again there was an increase in viscosity however this did 
not lead to an increase in bead size, as shown in figure 4.3 with a correlation coefficient of R2 value 
of 22%. This would indicate that the weight increase seen in the first pilot experiment can be 

























Effect of feed viscosity on bead size
 
Figure 4.3 Effect of feed viscosity on bead size (volume weighted mean) 
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Also the feed viscosity measured may not be a true reflection of the viscosity at the time of droplet 
formation, as the feed will encounter a shear field when passing through the aperture resulting in a 
reduction in viscosity due to the shear thinning nature of the alginate thickened feed (FMC, 2003). 
Using the smaller aperture produced beads within the required range of 1 to 2mm with a mean bead 
size of 1.295mm and a standard error of the mean of +/- 0.021mm . However at some viscosities it 
was not possible to produce beads as long strings were produced instead. In these cases the 
viscosities of the fluids were damping the internal waves to such an extent that a large column was 
produced before it broke. Once the column had broken the time taken to fall into the gelling 
solution was insufficient for the surface tension to pull the viscous column into a droplet (figure 3.1) 
To determine if the beads were suitable nutritionally the nitrogen content was analysed and the 
percentage recovery calculated with a target recovery of greater than 80% (DFS, 2014). A lower 
recovery would render the beads unsuitable, as the patient would be at risk of dietary protein and 
calorie deficit that would impact on their health. The recovery for the beads produced was between 
4% and 15% and as such is nutritionally poor. 
The method of bead manufacture used in the pilot experiment was prone to issues with the 
aperture blocking which impeded bead production. Blockages can occur when there is a particle size 
to tube diameter ratio of around 0.3 – 0.4 (Sharp 2005). The amino acid blend  used had a volume 
weighted mean diameter of 0.145mm and the aperture  had a diameter of 0.4mm.Therefore a tube 
to particle diameter ratio of 0.36 was produced which is within this range and therefore the blocking 
of the tube was inevitable.  However prior to a blockage forming the large particles can form an arch 
in the tube (Sharp 2005) thus straining the insoluble amino acids out of the feed stock in the 
aperture and therefore producing a droplet containing a reduced amino acid content and there may 
be inconsistencies in the initial amino acid content from bead to bead. 
4.2.4 Third pilot experiment 
In this experiment there were variations in the alginate content, amino acid and the calcium chloride 
contents as shown in table 3.2, however the combinations that produced strings were omitted.  
To reduce the blockages and improve the homogeneity the amino acid blend was milled to produce 
a smaller particle size. This reduced the volume weighted mean size from 0.145mm to 0.077mm and 
produced a particle to tube ratio of 0.19 that is below the 0.3 ratio responsible for blockages. When 
manufacturing the beads no blockages were encountered so the milling had a positive effect. The 
milling also produced larger and more consistent bead sizes compared to pilot experiment 2 as seen 
in table 4.0 
Table 4.0 Bead size comparison  




Pilot Experiment 2 1061 117.0 
Pilot Experiment 3 1294 70.9 
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Although the beads are larger than those produced in pilot experiment 2 they were still within the 1 
to 2mm size range required. Therefore the modified method of bead manufacture with the amino 
acids being milled and a 0.4mm aperture pipette was established as the standard method of 
manufacture for all subsequent experiments.      
Although the amino acid particle size reduction and the removal of straining prior to droplet 
formation produced a positive impact on the amino acid recovery with an increase when compared 
to pilot experiment 2, the recovery levels, between 14 and 38%, were still poor and sub optimal.   
To understand the poor recovery the structure of the beads needs to be considered. The beads are 
not a solid impermeable mass entrapping the soluble and insoluble amino acids but are a porous 
gelled network as seen in the photographs and SEM micrographs (figure 4.4) 
 
Fig 4.4 Photographs and SEM micrographs of an Alginate bead (Bellich, 2011) 
As a gelled network the diffusion of the amino acids contained is reduced when compared to a 
normal solution, however it is still possible for the amino acid to diffuse out of the network and into 
the gelling solution. 
Therefore whilst the beads were in the gelling solution overnight, the calcium was diffusing into the 
beads but at the same time the amino acids were diffusing out of the beads. Therefore the time in 
gelling solution used in the pilot experiment was too long and a shorter time was required in order 
for the calcium to gel the solution before the amino acids diffused out of the matrix. 
The percentage recovery of amino acids in the beads produced with 2% alginate was higher when 
compared to 1% alginate. This can be attributed to the increase in alginate producing a denser 
network (figure 4.5) which reduces the beads permeability and restricts the diffusion (Zeeb, 2015). 
Therefore the increase in alginate concentration had a positive effect on the amino acid recovery. 
 
 
High Alginate conc            Low Alginate conc 
Figure 4.5 Effect of Alginate on network density  (Rayment, 2009) 
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4.3 First design of experiment  
In these experiments a Plackett Burman factorial methodology was utilised in order to discover the 
relationships between the factors and their effect on the recovery without completing a large 
number of experiments. Three of the four factors available were chosen, alginate, calcium chloride 
concentration and the residence time in the gelling solution; with the amino acid recovery being an 
output. The alginate and the residence time were chosen as from the pilot experiment it was 
hypothesised that these would affect the recovery. The amino acid content was omitted as a factor 
as it was known from the pilot experiments that it was not physically possible to produce beads with 
a combination of higher levels of amino acid and alginate due to the increased viscosity of the feed 
solution.  The levels of 1% and 3% calcium chloride solution and 1% and 2% alginate where chosen as 
these were used successfully in the pilot experiments. The time in the gelling solution was reduced 
from overnight to between 5 and 20 minutes as it was indicated from the pilot experiments that 
overnight was too long. In addition to the two levels, centre points of 1.5% alginate,  2% calcium and 
12.5 minutes where included to increase the accuracy of the model and to check for linearity. 
Once the beads were manufactured the nitrogen was measured by Dumas method and the 
percentage recovery of amino acid calculated and inputted into the model (table 3.3).  
From the model a main effect chart and a Pareto chat were produced (figures 3.2 and 3.0) to 
determine which factors had an effect on the output. The alginate had the greatest effect as it had 
the largest magnitude on the Pareto chart and had the steepest gradient on the main effects plot. 
This finding was similar to the findings of the third pilot experiment and can be attributed to the 
reduction in the beads porosity due to the increase in the alginate concentration.   
The level of calcium also showed a significant effect on the output as its magnitude was greater than 
the reference line on the Pareto chart and the line is off the horizontal on the standard effects chart.  
The time in the gelling solution did not have a significant effect on the output as its magnitude is not 
greater than the reference line on the Pareto chart and the line is almost horizontal on the main 
effects plot. 
Both of these effects can be explained by diffusion. Diffusion can be described by Flicks first law 
where the rate of diffusion, or diffusion flow, over a given length is related to the concentration 
gradient and diffusion coefficient. As can be seen in table 4.1 the rates of diffusion of alanine and 
glycine, which make up over a quarter of the amino acids in the blend, were greater than that of the 
calcium in the gelling solution. 
Table 4.1 Calculated diffusion flows for amino acids and calcium  
Material Diffusion flow mol/m2s-1 
Alanine (1.36% sol) -2.51 x 106 
Glycine (1.31% sol) -3.39 x 106 
Calcium (1% Calcium chloride sol) -2.04 x 105 
Calcium (3% Calcium chloride sol) -5.90 x 105 
 
Therefore it was hypothesised that whilst the beads were in the gelling solution the calcium was 
diffusing into the beads. At the higher levels of calcium there was a greater diffusion gradient and 
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therefore a higher diffusion flow, and the rate at which the calcium diffused through the bead to the 
core was increased (Blandino, 1999). Therefore the alginate network which negatively affects the 
beads porosity will form faster and inhibit the amino acid loss (Bellich, 2011). 
However as the calcium is diffusing into the beads, the amino acids are diffusing out of the beads at 
a greater rate as indicated by the higher diffusion flow rates. Therefore  there may be no significant 
effect shown by the residence time in the gelling solution, as the majority of the amino acids have 
already diffused out of the beads by the five minute time point, thus the twenty minute time point 
will show no further effect.  
The percentage recovery from the experiments, between 30 and 52%, although better than the pilot 
studies, were still sub optimal and therefore further enhancements were needed to the bead 
production method. 
 
4.4 Second design of experiment  
In these experiments the findings from the previous experiments were used to update the Plackett 
Burman factorial design. The three factors and outputs used were the same ie. Alginate, calcium 
chloride, residence time in the gelling solution and recovery however the levels were changed (table 
3.4).  The levels of alginate were increased from 1 to 2%; to 1 to 3% as from the previous experiment 
it was shown that the level of alginate had a significant effect.  Although the residence time was 
shown not to be significant it was hypothesised that this was due to the residence times of 5 to 20 
minutes being too long with the majority of the amino acids already diffusing out of the beads within 
5 minutes. Therefore the levels for the residence time were reduced to 1 and 4 minutes. As the 
residence time had been reduced it was necessary to increase the rate of diffusion of the calcium so 
that the calcium can diffuse to the core and fully gel the bead without the amino acids diffusing out. 
The levels of 10 to 30% were chosen so that the rate of calcium diffusion was higher than that for 
the amino acids (table 4.2). 
Table 4.2 Calculated diffusion flows for amino acids and calcium  
Material Diffusion flow mol/m2s-1 
Alanine (1.36% sol) -2.51 x 106 
Glycine (1.31% sol) -3.39 x 106 
Calcium (10% Calcium chloride sol) -2.04 x 106 
Calcium (30% Calcium chloride sol) -5.9 x 106 
 
As in the previous experiments in addition to the two levels (calcium 10 and 30%, alginate 1 and 3% 
and residence time of 1 and 4 minutes), centre points of 2% alginate,  15% calcium and 2.5 minutes 
were included to increase the accuracy of the model and to check for linearity.  Once the beads were 
manufactured the nitrogen was measured by the Dumas method and the percentage recovery 
calculated and inputted into the model.  
From the output a Pareto chart and main effects plot were produced (figures 3.5 and 3.5) and it was 
seen that levels of alginate and residence time had an effect on the output as both were above the 
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line of significance on the Pareto chart and were not horizontal on the main effects plot. The level of 
alginate had the greatest effect overall with the steepest gradient in the main effects plot and the 
largest magnitude on the Pareto chart. The level of calcium was not significant as its level was below 
the significant line on the Pareto chart and was almost horizontal on the main effects plot. 
The effect of the alginate was similar to the effect in the first experiment with larger amount of 
alginate producing denser networks which reduced the beads permeability and further restricted 
the diffusion of the amino acids. 
The effect of the residence time was different to what was observed in the first experiment in which 
the residence time was not significant. Therefore the significance of the reduced residence time in 
this experiment shows that the amino acids rapidly diffused out of the beads.  Hence the hypothesis 
that the residence times used in the first experiment were too long was correct. 
The calcium level which was a significant factor in the first experiment was not significant in this 
experiment. The  lack of  significance can be explained, as although the increase in the level of 
calcium lead to an increase in the rate of diffusion (table 4.2) there was only a finite number of 
binding sites available on the alginate for the calcium bind to and gel (Blandino, 1999). Once all the 
sites were occupied and the matrix fully formed, any further increase in calcium did not affect the 
matrix and did not change the porosity. Thus the effects of the higher level of calcium were not seen 
as the matrix had fully formed and gelled within a minute. On visual examination of the beads it was 
noted than after only 1 minute in the gelling solution there was no visual difference between the 
beads formed with different levels of calcium, and all the beads appeared gelled and firm 
Therefore the reduction in residence time with an increase in calcium had a positive effect on amino 
acid recovery allowing for the calcium to diffuse at a sufficient rate to gel the beads before the 
amino acids had time to diffuse out of the bead.  
To model the relationship between the 3 factors (predictors) and the output, a linear regression 
model was used. However before this could be completed it was first necessary to determine if the 
residuals were normally distributed as if the residuals are non-normally distributed the output of the 
regression analysis cannot be trusted (Frost, 2014). Therefore a normal plot of the residuals was 
produced, (figure 3.6), and as the plots were close to the normal distribution line with no outliners 
the residual were normally distributed. 
The residuals were also plotted in order to determine if the output was derived from stochastic or 
deterministic errors. This was important as for the model to work correctly the randomness and 
unpredictability of stochastic errors was vital (Frost, 2012). On examining the residual plot (figure 
3.7) the residuals had a constant spread throughout the range with no values systematically high or 
low , therefore the errors were stochastic and no deterministic errors were affecting the residuals 
(Frost, 2012).  However an R2 value of 88.8% and an adjusted R2 value of 85% were achieved (table 
3.5) for the model.  In order to achieve higher R2 values and a more accurate model the stochastic 
errors needed to be reduced. This could be achieved by increasing the amount of replicates within 
the design of experiment and should be incorporated into any further work. 
To increase the model accuracy other regression models were investigated. When continuous 
predictors and outputs are used only linear and nonlinear models can be used. However nonlinear 
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regression analysis is difficult to achieve due to the large amount of functions that are available and 
therefore only linear regression was used (Frost, 2011). 
Another factor that was considered was multicollinearity, where predictors are correlated with other 
predictors. This leads to an increase in the standard errors of the regression coefficients of the 
predictors and can overinflate them making some variables statistically insignificant when they 
should be significant. To check for multicollinearity the variance inflation factor (VIF) was calculated, 
if the VIF was greater than 1 then there would be evidence of multicollinearity (Martz, 2013). The VIF 
was equal to 1 for all predictors in the model and therefore there was no multicollinearity present. 
The regression equation was determined with regression coefficients, associated P values and their 
standard errors (table 4.3) 
Table 4.3 Regression analysis outputs 
Predictor Coef SE Coef P 
Constant 46.638 5.705 0.000 
Calcium 0.3288 0.1668 0.080 
Alginate 10.194 1.668 0.000 
Time -6.067 1.112 0.000 
 
 
The regression equation is 
 
Percentage recovery of Amino acids = 46.6 + 0.329 Calcium + 10.2 Alginate - 6.07 Time 
 
From the regression equation it can be seen that the alginate has the largest effect on the output 
with a 10.2% increase in the output per unit of alginate increase. The residence time has the next 
largest effect on the output, for every unit of time decrease there is a 6.07% increase in the recovery 
(it was a decrease as residence time was negatively correlated). Calcium has the lowest effect on the 
output with only a 0.329% increase in recovery per unit increase in calcium.  The P values for the 
alginate and residence time are below 0.05 which shows that changes to these predictors values 
resulted in significant changes to the output. However the P value for the calcium is >0.05 with a 
value of 0.08, which can indicate that changes to this predictor did not have a significant effect on 
the output. This was expected as the Pareto chart and main effects plot did not show significance for 
calcium level therefore the regression equation was recalculated excluding calcium (table 4.4) 
Table 4.4 Regression analysis outputs (calcium omitted) 
Predictor Coef SE Coef P 
Constant 53.213 5.254   0.000 
Alginate 10.194     1.893    0.000   
Time -6.067     1.262   0.001   
 
The regression equation is 
 
Percentage recovery of Amino acids = 53.2 + 10.2 Alginate - 6.07 Time 
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As can be seen the regression coefficients for the predictors have not changed, but there has been 
an increase in the regression constant. The P values for all the predictors are still <0.05 and are 
therefore still significant. Therefore from the regression equation it was seen that for the highest 
recovery the sample needs the highest alginate concentration and needs to be in the gelling solution 
for the shortest time period. The samples produced with 1 minute residence time and 3% alginate 
produced the best recovery of 78% and 84 % which was acceptable. 
4.5 Digestion modelling  
For the digestion modelling an in vitro model was used. Due to the elemental composition of the 
beads and the insoluble fibre nature of the alginate no digestive enzymes were used. However 
simulated gastric and intestinal solutions were used with a simulated gastric digestion period of 90 
minutes and a simulated intestinal digestion period of 120 minutes carried out at 37oC to model the 
conditions of in vivo digestion (Rayment, 2009).  The nitrogen content of the beads was measured 
pre and post digestion to determine if the beads released the amino acids.  
After the digestion it was seen that the amino acid content of the beads had reduced from an initial 
amino acid content of 7.9g / 100g beads to 0.85g / 100g of beads, however the beads themselves 
were visually unaffected by the digestion.  
This can be attributed to the porous nature of the beads allowing the amino acids to diffuse out of 
the beads into the digestive fluids. It is known that due to alginate having a pKa of around 3.5, under 
acidic gastric conditions there is a change in the electrical characteristics, thus causing the alginate 
to lose its negative charge (Li, 2011). This results in the calcium ions dissociating from the gel 
junction zones allowing the alginate chains to come closer to each other causing the beads to 
contract and become less porous thus hampering diffusion. However in the more neutral intestinal 
conditions the beads will swell and become more porous thus allowing diffusion to occur at a higher 
rate (Rayment, 2009).  From the second and third pilot experiments it was known that the amino 
acids will diffuse out of the beads quickly thus the 210 minute digestion time was adequate for 89% 
of the amino acids to diffuse out.   The beads were not physically affected by the digestion which can 
be attributed to the alginate matrix being resistant to digestion.  This has been seen in in vivo studies 
where the beads were not broken down in digestion and visible on an NMR in the small intestine  
(Hoad, 2009).  
To determine the amount of amino acids digested the nitrogen content of the beads pre and post 
digestion was measured by Dumas, however amino acids contain differing amounts of nitrogen 
(FAO, 2002). Therefore measuring the nitrogen would not show if the amino acid composition of the 
bead was similar to the desired amino acid profile. A reduced nitrogen content, post digestion, could 
indicate a difference in the retention of particular amino acids within the beads, or that all the amino 
acids diffused out of the beads equally but not completely.  It was possible to measure amino acid 
composition by ion exchange chromatography, however this technique used a solvent extraction 
step that was not validated for the beads so could not be used. Therefore although the physical 
beads were not digested and amino acids diffused out and thus were bioavailable, the composition 




4.6 Food safety and sensory testing  
Before conducting the sensory testing it was necessary to check that the beads were safe for 
consumption, therefore the calcium and chloride content was measured by inductively coupled 
plasma spectrophotometry and a 926 Corning chloride analyser and compared to the dietary 
reference intake for an adult population. Although the calcium and chloride content of the beads 
were considerable, the amount of beads consumed in the sensory study was small therefore the 
amount of calcium and chloride consumed was below the reference nutritional intake and therefore 
was deemed safe. 
The beads were then exposed to a triangle test against a placebo product. The placebo product 
contained maltodextrin in place of the amino acids in the beads manufacture, utilising the same 
carrier. The output from the triangle test was that of the 12 participants, 6 correctly identified the 
different sample and 6 incorrectly identified the different sample. The amount of participants 
required to correctly identify the sample for significance at a 95% confident level was 8, therefore as 
only 6 participants correctly identified the sample it can be concluded that the amino acid bead is 
not significantly different to the placebo bead, and therefore the encapsulation has successfully 




5.0 Conclusion and recommendations 
 
From the experiments it can be concluded that to produce beads the alginate content, calcium 
chloride content and the residence time in the gelling solution are critical for both the physical 
manufacture of the bead and the retention of the amino acids within the bead.  The most successful 
beads in the study were the beads produced using a feed stock comprising 10% amino acids and 3% 
alginate dropped into a 10% calcium chloride solution with a residence time of 1 minute. 
Due to the effect on viscosity of the feed stock resulting in poor beads it was not possible to 
investigate the effect of higher amino acid contents. This could, however be achieved if  different 
techniques were utilised for bead manufacture which would accommodate higher viscosities such as 
spinning discs, instead of the dripping method used. 
Although physical bead characterisation was conducted using laser particle diffraction techniques 
this was limited to the size of the beads. It may be useful to use scanning electron microscopy and 
transmission electron microscopy in order to examine the surface topography and internal structure 
of the beads (Burey, 2008). 
Through the in vitro digestion model it was shown that although the amino acids were successfully 
encapsulated in the beads they were liberated during digestion and were bioavailable.  Ideally an in 
vivo study would be conducted to validate the model, however in vivo studies are expensive and 
time consuming to undertake. The in vitro study utilised the nitrogen content to determine the level 
of amino acids liberated, it may be beneficial for further investigations to use different analytical 
techniques to determine the amino acid composition post digestion rather than relying on nitrogen 
content alone. 
In the sensory study utilising a triangle test it was demonstrated that there was no significant 
difference between the amino acid containing beads and a placebo product. Although the triangle 
test used trained panellists that produce more accurate and reliable results, the number of 
participants was relatively low due to the manufacturing method. If it were possible to automate the 
manufacturing method to easily produce larger quantities of beads then a wider study with more 
participants could be conducted. 
Although a bead was successfully produced and consumed with a carrier, no shelf life study was 
completed. It would be necessary to complete a shelf life study of the bead and carrier to determine 
any changes to the bead integrity and organoleptic properties over time. 
Therefore the encapsulation of amino acids in an alginate bead can be used successfully as a delivery 
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